Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase

Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase

Thumbnail Image
Download
Name

nihms861963.pdf

Size

2.91 MB

Format

Adobe PDF

Checksum (MD5)

b9041ceca13cf93041317fce99a6bfb0

Download all files submitted through automated deposit
sword-2018-07-03.original.zip (2.11 MB)
Author(s)
Cantor, Jason R.
•
Abu-Remaileh, Monther
•
Kanarek, Naama
•
Freinkman, Elizaveta
•
Gao, Xin
•
Louissaint, Abner
•
Lewis, Caroline A.
•
Sabatini, David
Date Issued
April 2017
Journal
Cell
Publisher
Elsevier
Citation
Cantor, Jason R. et al. “Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase.” Cell 169, 2 (April 2017): 258–272 © 2017 Elsevier Inc
Version
Author's final manuscript
Abstract
A complex interplay of environmental factors impacts the metabolism of human cells, but neither traditional culture media nor mouse plasma mimic the metabolite composition of human plasma. Here, we developed a culture medium with polar metabolite concentrations comparable to those of human plasma (human plasma-like medium [HPLM]). Culture in HPLM, relative to that in traditional media, had widespread effects on cellular metabolism, including on the metabolome, redox state, and glucose utilization. Among the most prominent was an inhibition of de novo pyrimidine synthesis—an effect traced to uric acid, which is 10-fold higher in the blood of humans than of mice and other non-primates. We find that uric acid directly inhibits uridine monophosphate synthase (UMPS) and consequently reduces the sensitivity of cancer cells to the chemotherapeutic agent 5-fluorouracil. Thus, media that better recapitulates the composition of human plasma reveals unforeseen metabolic wiring and regulation, suggesting that HPLM should be of broad utility.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/116765
DOI of Published Version
https://doi.org/10.1016/J.CELL.2017.03.023
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.